The Bronchiectasis and NTM Association has accepted 27 Care Center and six Clinical Associate Center sites in 23 states and the District of Columbia into the new Bronchiectasis and NTM Care Center ...

The Bronchiectasis and NTM Association has accepted UC San Francisco (UCSF) into its Bronchiectasis and NTM Care Center Network (CCN), recognizing UCSF’s dedication to providing high-quality medical ...

Macrolide maintenance therapy in patients with bronchiectasis significantly reduces the risk for major adverse cardiovascular events.

OhtuvayreTM (ensifentrine) recorded net product sales of $36.6 million in Q4 and $42.3 million in 2024 More prescriptions filled through February 2025 than in Q4 2024 Over 4,600 unique prescribers wit ...

If you experience symptomatic gallstones, there are a number of different treatment options available. Your exact course of treatment will depend on your symptoms and the characteristics of the ...

Brensocatib represents a potential first-in-class treatment for bronchiectasis, a condition currently without any approved targeted therapies in the regions mentioned. The FDA's decision not to ...

“Should the Phase 3 data confirm the Phase 2 findings, we plan to meet with the FDA to discuss potential registrational pathways in this highly refractory population with minimal to no treatment ...

When Mr. Kristof’s friend Drew sought prison for treatment, he was desperate for help. Jail just happened to be the option in front of him. This illustrates just how out of reach addiction ...

His condition is complicated by a polymicrobial infection, making treatment challenging ... in the case of the pope who has underlined bronchiectasis and is on oral steroids as being reported ...

Following Pope Francis’ diagnosis of bilateral pneumonia, respiratory doctors are speaking about the condition. The Vatican announced the Catholic leader’s diagnosis this week.